F-18 Fluorodeoxyglucose PET/CT findings in a case of Anti-NMDA receptor encephalitis

Clinical Nuclear Medicine

Volumn 35, Issue 6, 2010, Pages 461-463

  Mohr, Brandt C ^a   Minoshima, Satoshi ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Anti NDMA receptor encephalitis; Brain; F 18 fluorodeoxyglucose (FDG); Positron emission tomography (PET)

Indexed keywords

AUTOANTIBODY; FLUORODEOXYGLUCOSE F 18; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; ARTICLE; BIPOLAR DISORDER; BRAIN METABOLISM; CASE REPORT; CEREBELLUM; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; ENCEPHALITIS; FEMALE; FRONTAL LOBE; HALLUCINATION; HUMAN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ENCEPHALITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; OROFACIAL DYSKINESIA; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; TEMPORAL LOBE;

AUTOANTIBODIES; ENCEPHALITIS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, N-METHYL-D-ASPARTATE; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 77952502759     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3181db4d4a     Document Type: Article

References (9)

1. Dalmau J, Tuzün E, Hai-yan W, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25-36. (Pubitemid 46214241)
2. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091-1098.
3. Florance NR, Davis RL, Lam C, et al. Anti-N-Methyl-D-Aspartate Receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009;66:11-18.
4. Iizuka T, Sakai F, Ide T, et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology. 2008;70:504-511.
5. Seki M, Suzuki S, Iizuka T, et al. Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry. 2008;79:324-326.
6. Dadparvar S, Anderson GS, Bhargava P, et al. Paraneoplastic encephalitis associated with cystic teratoma is detected by fluorodeoxyglucose positron emission tomography with negative magnetic resonance image findings. Clin Nucl Med. 2003;28:893-896.
7. Scheid R, Lincke T, Voltz R, et al. Serial 18F-fluoro-2-deoxy-D-glucose positron emission tomography and magnetic resonance imaging of paraneoplastic limbic encephalitis. Arch Neurol. 2004;61:1785-1789.
8. Basu S, Alavi A. Role of FDG PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates. Mol Imaging Biol. 2008;10:131-137.
9. Vollenweider FX, Leenders KL, Scharfetter C, et al. Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG). Eur Neuro-psychopharmacol. 1997;7:9-24. (Pubitemid 27139716)